Physician profile
Michael Dean Magee
NPI 1336240696
$289.68
in general payments reported to CMS, 2019-2025
7 companies · $75.90 in 2025
The $75.90 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.58 · 2022: $55.44 · 2023: $79.73 · 2024: $14.03 · 2025: $75.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $121.83 | 2023-2025 | Veozah |
| Pfizer INC. | $64.53 | 2021-2022 | |
| Avion Pharmaceuticals | $38.38 | 2021-2022 | |
| Edwards Lifesciences Corporation | $19.13 | 2023 | Sapien 3 Ultra Resilia |
| Olympus America INC. | $17.11 | 2021 | |
| Mayne Pharma Commercial LLC | $14.67 | 2025 | |
| Boston Scientific Corporation | $14.03 | 2024 | Advantage System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.